Oaktree Acquisition Corp. III Life Sciences Class A(OACC)
$10.72-0.00 (-0.05%)
OACC
Oaktree Acquisition Corp. III Life Sciences Class A similar stocks
$10.72
At close:-0.00 (-0.05%)
Compare Oaktree Acquisition Corp. III Life Sciences Class A (OACC) vs. Competitors
0 Followers
Comparison Results
| Name | Price | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Compare | Top Analysts' Price Target | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
| OACCOaktree Acquisition Corp. III Life Sciences Class A | $10.72 | $263.53M | 58.53 | 1.32% | ― | Unlock the OACC analyst price target with TipRanks Premium | OACC | Unlock the OACC top-analyst price target with TipRanks Premium | ||
| TDACTranslational Development Acquisition Corp. | $10.87 | $209.89M | -35.98 | 4.02% | ― | Unlock the TDAC analyst price target with TipRanks Premium | OACC vs TDAC | Unlock the TDAC top-analyst price target with TipRanks Premium | ||
| DMAADrugs Made In America Acquisition Corp. | $10.90 | $264.62M | 61.83 | 5.57% | ― | Unlock the DMAA analyst price target with TipRanks Premium | OACC vs DMAA | Unlock the DMAA top-analyst price target with TipRanks Premium | ||
| RACCResearch Alliance Corporation III Class A | $10.12 | $92.08M | ― | -1.75% | ― | Unlock the RACC analyst price target with TipRanks Premium | OACC vs RACC | Unlock the RACC top-analyst price target with TipRanks Premium |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| OACC | Oaktree Acquisition Corp. III Life Sciences Class A | 10.72 | 0.12 | 1.13% | |
| TDAC | Translational Development Acquisition Corp. | 10.87 | 0.46 | 4.42% | |
| DMAA | Drugs Made In America Acquisition Corp. | 10.90 | 0.57 | 5.52% | |
| RACC | Research Alliance Corporation III Class A | 10.12 | -0.18 | -1.75% |
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

